2.91
Sensus Healthcare Inc stock is traded at $2.91, with a volume of 6,598.
It is up +0.69% in the last 24 hours and down -3.64% over the past month.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.
See More
Previous Close:
$2.89
Open:
$2.93
24h Volume:
6,598
Relative Volume:
0.12
Market Cap:
$47.90M
Revenue:
$22.53M
Net Income/Loss:
$-7.77M
P/E Ratio:
-6.1289
EPS:
-0.4748
Net Cash Flow:
$-740.00K
1W Performance:
-3.96%
1M Performance:
-3.64%
6M Performance:
-43.27%
1Y Performance:
-47.94%
Sensus Healthcare Inc Stock (SRTS) Company Profile
Name
Sensus Healthcare Inc
Sector
Industry
Phone
561-922-5808
Address
851 BROKEN SOUND PARKWAY NW, BOCA RATON, FL
Compare SRTS vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
SRTS
Sensus Healthcare Inc
|
2.91 | 49.72M | 22.53M | -7.77M | -740.00K | -0.4748 |
|
ABT
Abbott Laboratories
|
105.74 | 182.00B | 46.59B | 5.41B | 7.38B | 3.0938 |
|
SYK
Stryker Corp
|
325.74 | 129.09B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
MDT
Medtronic Plc
|
85.40 | 107.81B | 36.36B | 4.84B | 5.43B | 3.7261 |
|
BSX
Boston Scientific Corp
|
46.73 | 67.64B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
86.03 | 47.81B | 6.30B | 1.07B | 1.09B | 1.8406 |
Sensus Healthcare Inc Stock (SRTS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-06-26 | Initiated | Alliance Global Partners | Buy |
| Jan-31-25 | Initiated | Lake Street | Buy |
| Nov-15-24 | Reiterated | Maxim Group | Buy |
| Feb-26-21 | Upgrade | Northland Capital | Market Perform → Outperform |
| Dec-16-20 | Downgrade | Northland Capital | Outperform → Market Perform |
| Aug-10-20 | Upgrade | Alliance Global Partners | Neutral → Buy |
| Feb-14-20 | Upgrade | Alliance Global Partners | Neutral → Buy |
| Nov-07-19 | Downgrade | B. Riley FBR | Buy → Neutral |
| Jan-29-19 | Downgrade | Northland Capital | Market Perform → Under Perform |
| Sep-26-18 | Initiated | B. Riley FBR | Buy |
| Nov-03-17 | Reiterated | Maxim Group | Buy |
| Jun-06-17 | Initiated | Maxim Group | Buy |
| Aug-08-16 | Initiated | Northland Capital | Outperform |
View All
Sensus Healthcare Inc Stock (SRTS) Latest News
Sensus Healthcare Inc (SRTS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
SRTS|Sensus Healthcare Inc|Price:3.055|Chg%:+0.025 - TradingKey
Sensus Healthcare Inc (SRTS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Sensus Healthcare Inc (SRTS) Cash Flow - TradingKey
Sensus Healthcare Inc (SRTS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Sensus Healthcare, Inc. Revenue Breakdown – LS:A2JPJ1 - TradingView
SRTS|Sensus Healthcare Inc|Price:3.030|Chg%:+0.090 - TradingKey
TradingKey - TradingKey
Sensus Healthcare Inc (SRTS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Sensus Healthcare, Inc. Revenue Breakdown – TRADEGATE:5TX - TradingView
Sensus Healthcare Inc (SRTS) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
SRTS Q2'26 Earnings: revenue estimate is 4.60M USD - TradingView
Sensus Healthcare (SRTS) Holds Steady at $3.08 as Support and Resistance Levels TightenGEX Level - dars.gov.et
Sensus Healthcare (SRTS) Q4 2025 earnings summary - Quartr
Lake Street Maintains Sensus Healthcare(SRTS.US) With Buy Rating, Maintains Target Price $4.5 - Moomoo
Earnings call transcript: Sensus Healthcare misses Q1 2026 forecasts - Investing.com
Sensus Healthcare (SRTS) Holds Steady at $3.02 Amid Key Support and Resistance LevelsWyckoff Distribution - dars.gov.et
Tecsys Inc (TCYSF) Q4 2026 Earnings Call Highlights: Record Revenue and Strategic Growth Amid ... - Yahoo Finance
SRTS Q1 2026 Earnings: EPS Misses Estimates, Stock Rises 3.05%Earnings Growth Forecast - dars.gov.et
Sensus Healthcare, Inc. (SRTS) Investigation: Bronstein, Gewirtz - The National Law Review
Sensus Healthcare Company Profile & Introduction - Moomoo
Sensus Healthcare, Inc. Actuals & Estimates (NASDAQ:SRTS) - TradingView
Sensus Healthcare, Inc. Actuals & Estimates (LSX:A2JPJ1) - TradingView
Enterprise value to revenue forward of Sensus Healthcare, Inc. – NASDAQ:SRTS - TradingView
Price to earnings forward of Sensus Healthcare, Inc. – NASDAQ:SRTS - TradingView
Sensus Healthcare, Inc. Actuals & Estimates (TRADEGATE:5TX) - TradingView
Enterprise value to EBITDA forward of Sensus Healthcare, Inc. – NASDAQ:SRTS - TradingView
Price to sales forward of Sensus Healthcare, Inc. – NASDAQ:SRTS - TradingView
Spok Announces Sale of Spectrum Licenses to Sensus - Yahoo Finance
Sensus Healthcare Inc (SRTS) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Sensus Healthcare Inc (SRTS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Sensus Healthcare Inc (SRTS) Valuation: PE, PB & Fair Value Analysis - TradingKey
Sensus Healthcare Inc (SRTS) Institutional Confidence - TradingKey
SRTS to Host Virtual Meeting on June 18 - GuruFocus
Sensus Healthcare Stock Plummets to New 52-Week Low of $2.67 - MarketsMojo
Sensus Healthcare Stock Plummets to New 52-Week Low of $2.68 - MarketsMojo
Sensus Healthcare Stock Hits New 52-Week Low at $2.85 - MarketsMojo
Sensus Healthcare (SRTS) Holds Steady Near Support as Sector Rotation UnfoldsGamma Flip Level - newsline.com
Sensus Healthcare Secures New $15 Million Credit Facility - The Globe and Mail
Sensus HealthcareEnters $15 Million Revolving Credit Facility With City National Bank Of FloridaSEC Filing - TradingView
Sensus Healthcare (NASDAQ: SRTS) adds $15M secured credit facility - Stock Titan
Sensus Healthcare, Inc. Files Form 8-K with SEC – Company Details and Filing Information for May 2026 - Minichart
Sensus Healthcare shareholders re-elect directors and approve auditor at annual meeting By Investing.com - Investing.com South Africa
Sensus Healthcare shareholders re-elect directors and approve auditor at annual meeting - Investing.com India
Sensus Healthcare Shareholders Back Board, Pay, and Auditor - TipRanks
Sensus Healthcare (SRTS) 2026 meeting backs directors, pay and 2026 auditor - Stock Titan
Insiders Give Up US$51k As Sensus Healthcare Stock Drops To US$2.85 - simplywall.st
A SpaceX-Tesla union would mark the largest merger of all time. But does the math work? - Fortune
Sharps Technology Appoints Arthur Levine as Chief Financial Officer - The Globe and Mail
Sensus Healthcare (SRTS) Holds Tight Range After Minor DeclineDark Pool Prints - The Legal Advocate
IPO veteran Arthur Levine takes CFO post at fintech firm SkyAI - Stock Titan
Sensus Healthcare Inc Stock (SRTS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Sensus Healthcare Inc Stock (SRTS) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Sachetta Eric | Director |
Feb 24 '26 |
Buy |
3.81 |
2,000 |
7,620 |
142,113 |
| Sachetta Eric | Director |
Nov 21 '25 |
Buy |
3.93 |
7,000 |
27,510 |
140,113 |
| Sachetta Eric | Director |
Nov 13 '25 |
Buy |
4.50 |
2,500 |
11,250 |
133,113 |
| Sardano Joseph C | CHIEF EXECUTIVE OFFICER |
Nov 18 '25 |
Buy |
4.03 |
25,000 |
100,750 |
1,200,293 |
| Sardano Michael | PRESIDENT AND GENERAL COUNSEL |
Nov 18 '25 |
Buy |
3.80 |
1,000 |
3,800 |
118,839 |
| Sardano Michael | PRESIDENT AND GENERAL COUNSEL |
Nov 11 '25 |
Buy |
4.26 |
1,000 |
4,260 |
117,839 |
| Sardano Michael | PRESIDENT AND GENERAL COUNSEL |
Aug 13 '25 |
Buy |
3.37 |
1,000 |
3,370 |
116,839 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):